The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular analyses of metastatic collecting ducts renal cell carcinoma from the phase 2 prospective trial of cabozantinib as first-line treatment (BONSAI trial Meeturo 2).
 
Katia Todoerti
No Relationships to Disclose
 
Pierangela Sepe
No Relationships to Disclose
 
Devecchi Andrea
No Relationships to Disclose
 
Adele Busico
No Relationships to Disclose
 
Luca Agnelli
No Relationships to Disclose
 
Federica Perrone
No Relationships to Disclose
 
Chiara Gargiuli
No Relationships to Disclose
 
Matteo Dugo
No Relationships to Disclose
 
Loris De Cecco
Research Funding - Bristol Myers Squibb Foundation (Inst)
 
Melanie Claps
No Relationships to Disclose
 
Giuseppe Fotia
No Relationships to Disclose
 
Valentina Guadalupi
No Relationships to Disclose
 
Elena Verzoni
Consulting or Advisory Role - Janssen Oncology; Pfizer
Speakers' Bureau - Ipsen; Novartis
 
Giuseppe Procopio
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb (BMS); Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer